We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-16.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$11.7B
AUM Growth
-$2.52B
(-18%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
289
New
40
Increased
99
Reduced
91
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$204M |
| 2 |
McDonald's
MCD
|
+$105M |
| 3 |
IBM
IBM
|
+$98M |
| 4 |
Bank of America
BAC
|
+$96.5M |
| 5 |
Broadcom
AVGO
|
+$74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$232M |
| 2 |
Wells Fargo
WFC
|
+$98.7M |
| 3 |
CME Group
CME
|
+$93.9M |
| 4 |
Celanese
CE
|
+$92.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$90.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.14% |
| 2 | Healthcare | 17.2% |
| 3 | Industrials | 12.75% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Nektar Therapeutics
NKTR
$2.57B
| $830K | 0.01% |
1,683
-16,001
| -90% | -$9.66M |
|
227
SPDR Gold Trust
GLD
$141B
| $764K | 0.01% |
6,300
| – | – |
|
228
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $750K | 0.01% |
+13,190
| New | +$802K |
|
229
Innovative Industrial Properties
IIPR
$1.72B
| $640K | 0.01% |
+14,100
| New | +$647K |
|
230
Bread Financial
BFH
$4.36B
| $503K | ﹤0.01% |
4,198
| – | – |
|
231
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $495K | ﹤0.01% |
+1,980
| New | +$534K |
|
|
LGF.A
232
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $447K | ﹤0.01% |
27,795
| – | – |
|
|
TRVG
233
trivago
TRVG
$400M
| $399K | ﹤0.01% |
14,180
+2,220
| +19% | +$66.1K |
|
234
Boyd Gaming
BYD
$6.07B
| $391K | ﹤0.01% |
18,820
-37,390
| -67% | -$983K |
|
|
EXAS
235
DELISTED
Exact Sciences
EXAS
| $379K | ﹤0.01% |
+6,000
| New | +$412K |
|
236
West Pharmaceutical
WST
$24.9B
| $363K | ﹤0.01% |
3,700
| – | – |
|
237
Aptiv
APTV
$10.2B
| $360K | ﹤0.01% |
5,852
-1,001,806
| -99% | -$72.6M |
|
238
PVH
PVH
$4.05B
| $325K | ﹤0.01% |
3,500
-309,039
| -99% | -$35.4M |
|
239
iShares Russell 2000 ETF
IWM
$83.1B
| $323K | ﹤0.01% |
+2,415
| New | +$360K |
|
240
Ventas
VTR
$47.6B
| $276K | ﹤0.01% |
4,719
| – | – |
|
241
Arista Networks
ANET
$238B
| – | – |
-1,160,336
| Closed | -$19.3M |
|
242
Axalta
AXTA
$8.17B
| – | – |
-14,200
| Closed | -$414K |
|
243
Alibaba
BABA
$307B
| – | – |
-538,340
| Closed | -$88.7M |
|
244
BGC Group
BGC
$4.88B
| – | – |
-4,526,289
| Closed | -$34.4M |
|
|
245
Bristol-Myers Squibb
BMY
$132B
| – | – |
-1,463,591
| Closed | -$90.9M |
|
246
Carnival Corporation Ltd
CCL
$39.7B
| – | – |
-1,367,929
| Closed | -$87.2M |
|
|
VISN
247
Vistance Networks Inc
VISN
$2.52B
| – | – |
-780,552
| Closed | -$24M |
|
248
Camden Property Trust
CPT
$11.1B
| – | – |
-111,931
| Closed | -$10.5M |
|
249
Expedia Group
EXPE
$37.4B
| – | – |
-235,603
| Closed | -$30.7M |
|
|
KYNB
250
Kyntra Bio
KYNB
$29.2M
| – | – |
-8,383
| Closed | -$12.7M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Westfield Capital Management held 289 positions worth $11.7B, down 18% from $14.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q4 2018 filing shows 40 new, 99 increased, 91 reduced and 49 closed positions. Its largest new stake was Marathon Petroleum: 2,982,907 shares worth $176M. The largest sale was Andeavor, an estimated $232M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2018 buy was Marathon Petroleum: 2,982,907 shares worth $176M.
- Westfield Capital Management added most to IBM in Q4 2018, an estimated $98M increase.
- Westfield Capital Management's biggest Q4 2018 reduction was CME Group, cutting an estimated $93.9M.
- Westfield Capital Management fully exited Andeavor in Q4 2018, selling an estimated $232M.
- Westfield Capital Management's ten largest holdings make up 19% of its $11.7B portfolio in Q4 2018.
- Westfield Capital Management opened 40 new positions and closed 49 in Q4 2018.
- Westfield Capital Management's portfolio value fell 18% quarter-over-quarter to $11.7B.
Based on Westfield Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.